ReWalk Robotics Ltd. - Ordinary Shares (RWLK): Price and Financial Metrics
GET POWR RATINGS... FREE!
RWLK POWR Grades
- Sentiment is the dimension where RWLK ranks best; there it ranks ahead of 78.16% of US stocks.
- The strongest trend for RWLK is in Quality, which has been heading up over the past 163 days.
- RWLK ranks lowest in Quality; there it ranks in the 18th percentile.
RWLK Stock Summary
- REWALK ROBOTICS LTD's market capitalization of $40,149,089 is ahead of only 12.57% of US-listed equities.
- For RWLK, its debt to operating expenses ratio is greater than that reported by just 9.5% of US equities we're observing.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.07 for REWALK ROBOTICS LTD; that's greater than it is for just 7.3% of US stocks.
- If you're looking for stocks that are quantitatively similar to REWALK ROBOTICS LTD, a group of peers worth examining would be CVV, SNES, REFR, KVHI, and CRSR.
- Visit RWLK's SEC page to see the company's official filings. To visit the company's web site, go to www.rewalk.com.
RWLK Valuation Summary
- RWLK's price/sales ratio is 7.3; this is 55.32% higher than that of the median Healthcare stock.
- Over the past 104 months, RWLK's price/sales ratio has gone down 162.5.
Below are key valuation metrics over time for RWLK.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| RWLK | 2023-03-24 | 7.3 | 0.6 | -2.0 | 1.4 |
| RWLK | 2023-03-23 | 7.0 | 0.6 | -2.0 | 1.5 |
| RWLK | 2023-03-22 | 6.9 | 0.6 | -1.9 | 1.5 |
| RWLK | 2023-03-21 | 7.1 | 0.6 | -2.0 | 1.5 |
| RWLK | 2023-03-20 | 7.2 | 0.6 | -2.0 | 1.4 |
| RWLK | 2023-03-17 | 7.7 | 0.6 | -2.2 | 1.3 |
RWLK Growth Metrics
- Its 3 year price growth rate is now at -71.83%.
- Its 5 year cash and equivalents growth rate is now at -3.07%.
- The 3 year net cashflow from operations growth rate now stands at -0.02%.
The table below shows RWLK's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-12-31 | 5.511 | -17.891 | -19.569 |
| 2022-09-30 | 4.574 | -16.544 | -18.114 |
| 2022-06-30 | 5.66 | -14.506 | -15.329 |
| 2022-03-31 | 5.526 | -14.004 | -14.024 |
| 2021-12-31 | 5.966 | -11.469 | -12.736 |
| 2021-09-30 | 5.942 | -11.361 | -11.823 |
RWLK's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- RWLK has a Quality Grade of D, ranking ahead of 8.45% of graded US stocks.
- RWLK's asset turnover comes in at 0.094 -- ranking 156th of 186 Medical Equipment stocks.
- RSLS, PETV, and POAI are the stocks whose asset turnover ratios are most correlated with RWLK.
The table below shows RWLK's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.094 | 0.472 | -2.486 |
| 2021-03-31 | 0.131 | 0.510 | -2.172 |
| 2020-12-31 | 0.172 | 0.498 | -2.149 |
| 2020-09-30 | 0.177 | 0.575 | -2.023 |
| 2020-06-30 | 0.192 | 0.570 | -1.843 |
| 2020-03-31 | 0.147 | 0.536 | -1.873 |
RWLK Price Target
For more insight on analysts targets of RWLK, see our RWLK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $3.50 | Average Broker Recommendation | 1.5 (Moderate Buy) |
RWLK Stock Price Chart Interactive Chart >
RWLK Price/Volume Stats
| Current price | $0.66 | 52-week high | $1.21 |
| Prev. close | $0.69 | 52-week low | $0.63 |
| Day low | $0.65 | Volume | 95,300 |
| Day high | $0.70 | Avg. volume | 219,702 |
| 50-day MA | $0.78 | Dividend yield | N/A |
| 200-day MA | $0.89 | Market Cap | 38.96M |
ReWalk Robotics Ltd. - Ordinary Shares (RWLK) Company Bio
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals. The company was founded in 2001 and is based in Yokneam Ilit, Israel.
Latest RWLK News From Around the Web
Below are the latest news stories about REWALK ROBOTICS LTD that investors may wish to consider to help them evaluate RWLK as an investment opportunity.
Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and CurbsParalyzed individuals with spinal cord injury will have unprecedented access to walking in everyday environments as they are no longer limited when encountering stairs and curbs ReWalk Users Now Able to Access Stairs and Curbs in the US A paralyzed individual walks up the stairs to visit a friend's home using her ReWalk Personal Exoskeleton. MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd., (Nasdaq: RWLK) (“ReWalk” or the “Company”), |
ReWalk Robotics Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsReWalk Robotics ( NASDAQ:RWLK ) Full Year 2022 Results Key Financial Results Net loss: US$19.6m (loss widened by 54... |
ReWalk Robotics (RWLK) Reports Q4 Loss, Tops Revenue EstimatesReWalk (RWLK) delivered earnings and revenue surprises of -28.57% and 3.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |
ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial ResultsStrong Conclusion to 2022 – Q4’22 Revenue Highest Since Start of COVID-19 Pandemic Record Quarterly MyoCycle Sales Supplement Improved Exoskeleton Revenue MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurologic |
ReWalk Robotics to Report Fourth Quarter and Fiscal Year-End 2022 Financial Results on February 23, 2023MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 16, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and fiscal year-end 2022 financial results on Thursday, February 23, 2023, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call to discuss the results as follows: Time8:30 A.M ESTToll free (U.S. |
RWLK Price Returns
| 1-mo | -11.05% |
| 3-mo | -7.04% |
| 6-mo | -22.73% |
| 1-year | -42.11% |
| 3-year | 43.70% |
| 5-year | -97.60% |
| YTD | -13.17% |
| 2022 | -38.20% |
| 2021 | -6.82% |
| 2020 | -38.89% |
| 2019 | -50.34% |
| 2018 | -84.18% |
Continue Researching RWLK
Here are a few links from around the web to help you further your research on ReWalk Robotics Ltd's stock as an investment opportunity:ReWalk Robotics Ltd (RWLK) Stock Price | Nasdaq
ReWalk Robotics Ltd (RWLK) Stock Quote, History and News - Yahoo Finance
ReWalk Robotics Ltd (RWLK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...